Evolent Health, Inc. (FRA:9EH)
3.400
+0.080 (2.41%)
At close: Dec 5, 2025
Evolent Health Revenue
Evolent Health had revenue of $479.53M USD in the quarter ending September 30, 2025, a decrease of -22.83%. This brings the company's revenue in the last twelve months to $2.05B, down -16.65% year-over-year. In the year 2024, Evolent Health had annual revenue of $2.55B with 30.09% growth.
Revenue (ttm)
$2.05B
Revenue Growth
-16.65%
P/S Ratio
0.22
Revenue / Employee
$456.46K
Employees
4,500
Market Cap
377.97M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.55B | 590.85M | 30.09% |
| Dec 31, 2023 | 1.96B | 611.88M | 45.26% |
| Dec 31, 2022 | 1.35B | 444.06M | 48.91% |
| Dec 31, 2021 | 907.96M | -16.68M | -1.80% |
| Dec 31, 2020 | 924.64M | 237.52M | 34.57% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |